Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in J Acquir Immune Defic Syndr

Retrieve available abstracts of 406 articles:
HTML format
Text format



Single Articles


    June 2017
  1. NEWMAN OWIREDU M, Bellare NB, Chakanyuka Musanhu CC, Oyelade TA, et al
    Building Health System Capacity Through Implementation Research: Experience of INSPIRE-A Multi-country PMTCT Implementation Research Project.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S240-S247.
    PubMed     Text format     Abstract available


  2. MCCARTHY E, Joseph J, Foster G, Mangwiro AZ, et al
    Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and Zimbabwe.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S233-S239.
    PubMed     Text format     Abstract available


  3. CATALDO F, Sam-Agudu NA, Phiri S, Shumba B, et al
    The Roles of Expert Mothers Engaged in Prevention of Mother-to-Child Transmission (PMTCT) Programs: A Commentary on the INSPIRE Studies in Malawi, Nigeria, and Zimbabwe.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S224-S232.
    PubMed     Text format     Abstract available


  4. ORNE-GLIEMANN J, Font H, Maphosa T, Kangwende A, et al
    Patterns of Attendance at Mother Support Groups in Zimbabwe. The EPAZ Trial (2014-2016).
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S216-S223.
    PubMed     Text format     Abstract available


  5. FOSTER G, Orne-Gliemann J, Font H, Kangwende A, et al
    Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S207-S215.
    PubMed     Text format     Abstract available


  6. ERLWANGER AS, Joseph J, Gotora T, Muzunze B, et al
    Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S198-S206.
    PubMed     Text format     Abstract available


  7. JOSEPH J, Gotora T, Erlwanger AS, Mushavi A, et al
    Impact of Point-of-Care CD4 Testing on Retention in Care Among HIV-Positive Pregnant and Breastfeeding Women in the Context of Option B+ in Zimbabwe: A Cluster Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S190-S197.
    PubMed     Text format     Abstract available


  8. SAM-AGUDU NA, Ramadhani HO, Isah C, Erekaha S, et al
    The Impact of Structured Mentor Mother Programs on Presentation for Early Infant Diagnosis Testing in Rural North-Central Nigeria: A Prospective Paired Cohort Study.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S182-S189.
    PubMed     Text format     Abstract available


  9. SAM-AGUDU NA, Ramadhani HO, Isah C, Anaba U, et al
    The Impact of Structured Mentor Mother Programs on 6-Month Postpartum Retention and Viral Suppression among HIV-Positive Women in Rural Nigeria: A Prospective Paired Cohort Study.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S173-S181.
    PubMed     Text format     Abstract available


  10. OSIBO B, Oronsaye F, Alo OD, Phillips A, et al
    Using Small Tests of Change to Improve PMTCT Services in Northern Nigeria: Experiences From Implementation of a Continuous Quality Improvement and Breakthrough Series Program.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S165-S172.
    PubMed     Text format     Abstract available


  11. OYELEDUN B, Phillips A, Oronsaye F, Alo OD, et al
    The Effect of a Continuous Quality Improvement Intervention on Retention-In-Care at 6 Months Postpartum in a PMTCT Program in Northern Nigeria: Results of a Cluster Randomized Controlled Study.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S156-S164.
    PubMed     Text format     Abstract available


  12. HOSSEINIPOUR M, Nelson JAE, Trapence C, Rutstein SE, et al
    Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S149-S155.
    PubMed     Text format     Abstract available


  13. PHIRI S, Tweya H, van Lettow M, Rosenberg NE, et al
    Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi).
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S140-S148.
    PubMed     Text format     Abstract available


  14. GUNDA A, Jousset A, Tchereni T, Joseph J, et al
    Integrating HIV and Maternal, Neonatal and Child Health Services in Rural Malawi: An Evaluation of the Implementation Processes and Challenges.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S132-S139.
    PubMed     Text format     Abstract available


  15. MWAPASA V, Joseph J, Tchereni T, Jousset A, et al
    Impact of Mother-Infant Pair Clinics and Short-Text Messaging Service (SMS) Reminders on Retention of HIV-Infected Women and HIV-Exposed Infants in eMTCT Care in Malawi: A Cluster Randomized Trial.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S123-S131.
    PubMed     Text format     Abstract available


  16. MYER L, Phillips TK
    Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S115-S122.
    PubMed     Text format     Abstract available


  17. ROLLINS NC, Essajee SM, Bellare N, Doherty M, et al
    Improving Retention in Care Among Pregnant Women and Mothers Living With HIV: Lessons From INSPIRE and Implications for Future WHO Guidance and Monitoring.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S111-S114.
    PubMed     Text format     Abstract available


  18. BLAIS P, Sirivar S, Seto J
    Supporting Implementation Research to Improve Coverage and Uptake of HIV Related Interventions.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S109-S110.
    PubMed     Text format     Abstract available


  19. TEERAANANCHAI S, Bunupuradah T, Puthanakit T, Kerr SJ, et al
    First-Line Antiretroviral Treatment Outcomes and Durability in HIV-Infected Children Treated Through the Universal Coverage Health Program in Thailand.
    J Acquir Immune Defic Syndr. 2017;75:219-225.
    PubMed     Text format     Abstract available


  20. LUI G, Ma RCW, Chook P, Wong CK, et al
    Brief Report: Progression of Atherosclerosis in HIV-Infected Individuals-Prospective Data From an Asian Cohort.
    J Acquir Immune Defic Syndr. 2017;75:198-202.
    PubMed     Text format     Abstract available


  21. KASAIE P, Pennington J, Shah MS, Berry SA, et al
    The Impact of Preexposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model.
    J Acquir Immune Defic Syndr. 2017;75:175-183.
    PubMed     Text format     Abstract available


    May 2017
  22. VARIAVA E, Sigauke FR, Norman J, Rakgokong M, et al
    Late efavirenz-induced ataxia and encephalopathy: a case series.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001451.
    PubMed     Text format     Abstract available


  23. CHAWANA TD, Gandhi M, Nathoo K, Ngara B, et al
    Defining a cut-off for atazanavir in hair samples associated with virological failure among adolescents failing second-line antiretroviral treatment.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001452.
    PubMed     Text format     Abstract available


  24. KELLY SG, Krueger KM, Grant JL, Penugonda S, et al
    Statin prescribing practices in the comprehensive care for HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001454.
    PubMed     Text format    


  25. BROWN SA, Abbas S, Davies MA, Bunupuradah T, et al
    Pediatric Cancer Burden and Treatment Resources within the Pediatric IeDEA Consortium.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001453.
    PubMed     Text format     Abstract available


  26. DROZD DR, Kitahata MM, Althoff KN, Zhang J, et al
    Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001450.
    PubMed     Text format     Abstract available


  27. TSAI YT, Chen YC, Hsieh CY, Ko WC, et al
    Incidence of Neurological Disorders among HIV-Infected Individuals with Universal Health Care in Taiwan, 2000 through 2010.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001448.
    PubMed     Text format     Abstract available


  28. CRESSEY TR, Punyawudho B, Le Coeur S, Jourdain G, et al
    Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.
    J Acquir Immune Defic Syndr. 2017 May 9. doi: 10.1097/QAI.0000000000001447.
    PubMed     Text format     Abstract available


  29. VUJKOVIC M, Bellamy SL, Zuppa AF, Gastonguay M, et al
    CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-treated HIV-Infected Patients in Botswana.
    J Acquir Immune Defic Syndr. 2017 May 5. doi: 10.1097/QAI.0000000000001442.
    PubMed     Text format     Abstract available


  30. CHEN YH, McFarland W, Raymond HF, Scott HM, et al
    Distribution of behavioral patterns prior to infection among San Francisco men who have sex with men newly infected with HIV in 2014.
    J Acquir Immune Defic Syndr. 2017 May 5. doi: 10.1097/QAI.0000000000001439.
    PubMed     Text format     Abstract available


  31. MALEE KM, Chernoff MC, Sirois PA, Williams PL, et al
    Impact of Perinatally Acquired HIV Disease Upon Longitudinal Changes in Memory and Executive Functioning.
    J Acquir Immune Defic Syndr. 2017 May 5. doi: 10.1097/QAI.0000000000001441.
    PubMed     Text format     Abstract available


  32. LUAN H, Han X, Yu X, An M, et al
    Dual infection contributes to rapid disease progression in men who have sex with men in China.
    J Acquir Immune Defic Syndr. 2017 May 2. doi: 10.1097/QAI.0000000000001420.
    PubMed     Text format     Abstract available


  33. IZZO I, Quiros-Roldan E, Casari S, Gargiulo F, et al
    Characteristics and Outcome of a Cohort of HIV-1 Non-B Subtype-Infected Patients After a 10-Year Follow-up Period: A Single Centre Experience.
    J Acquir Immune Defic Syndr. 2017;75:e23-e24.
    PubMed     Text format    


  34. PATEL RC, Baeten JM, Heffron R, Hong T, et al
    Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.
    J Acquir Immune Defic Syndr. 2017;75:91-96.
    PubMed     Text format     Abstract available


  35. GOOSBY E, Abrams E, Bekker LG, Mushavi A, et al
    Crossing the Finish Line.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S106-S107.
    PubMed     Text format    


  36. VITILLO RJ, Merico F, Levine AS, Buonocore T, et al
    A Comprehensive Response: The Role of Nonstate Actors in the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S99-S105.
    PubMed     Text format     Abstract available


  37. LYONS C, Pillay Y
    Understanding the Role and Impact of Effective Country and Community Leadership in Progress Toward the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S94-S98.
    PubMed     Text format     Abstract available


  38. MATHESON R, Brion S, Sharma A, Dilmitis S, et al
    Realizing the Promise of the Global Plan: Engaging Communities and Promoting the Health and Human Rights of Women Living With HIV.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S86-S93.
    PubMed     Text format     Abstract available


  39. MODI S, Callahan T, Rodrigues J, Kajoka MD, et al
    Overcoming Health System Challenges for Women and Children Living With HIV Through the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S76-S85.
    PubMed     Text format     Abstract available


  40. RADIN AK, Abutu AA, Okwero MA, Adler MR, et al
    Confronting Challenges in Monitoring and Evaluation: Innovation in the Context of the Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S66-S75.
    PubMed     Text format     Abstract available


  41. PENAZZATO M, Amzel A, Abrams EJ, Kiragu K, et al
    Pediatric Treatment Scale-Up: The Unfinished Agenda of the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S59-S65.
    PubMed     Text format     Abstract available


  42. ESSAJEE S, Bhairavabhotla R, Penazzato M, Kiragu K, et al
    Scale-up of Early Infant HIV Diagnosis and Improving Access to Pediatric HIV Care in Global Plan Countries: Past and Future Perspectives.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S51-S58.
    PubMed     Text format     Abstract available


  43. KALUA T, Tippett Barr BA, van Oosterhout JJ, Mbori-Ngacha D, et al
    Lessons Learned From Option B+ in the Evolution Toward "Test and Start" From Malawi, Cameroon, and the United Republic of Tanzania.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S43-S50.
    PubMed     Text format     Abstract available


  44. KIRAGU K, Collins L, Von Zinkernagel D, Mushavi A, et al
    Integrating PMTCT Into Maternal, Newborn, and Child Health and Related Services: Experiences From the Global Plan Priority Countries.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S36-S42.
    PubMed     Text format     Abstract available


  45. HAMILTON E, Bossiky B, Ditekemena J, Esiru G, et al
    Using the PMTCT Cascade to Accelerate Achievement of the Global Plan Goals.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S27-S35.
    PubMed     Text format     Abstract available


  46. ABDOOL KARIM Q, Baxter C, Birx D
    Prevention of HIV in Adolescent Girls and Young Women: Key to an AIDS-Free Generation.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S17-S26.
    PubMed     Text format     Abstract available


  47. LUO C, Hirnschall G, Rodrigues J, Romano S, et al
    Translating Technical Support Into Country Action: The Role of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan Era.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S7-S16.
    PubMed     Text format     Abstract available


  48. HAROZ D, von Zinkernagel D, Kiragu K
    Development and Impact of the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S2-S6.
    PubMed     Text format     Abstract available


  49. O'NEILL TJ, Djiometio Nguemo J, Tynan AM, Burchell AN, et al
    Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis.
    J Acquir Immune Defic Syndr. 2017 May 1. doi: 10.1097/QAI.0000000000001433.
    PubMed     Text format     Abstract available


    April 2017
  50. GONSALVES GS, Paltiel AD, Cleary PD, Gill MJ, et al
    A Flow-Based Model of the HIV Care Continuum in the United States.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001429.
    PubMed     Text format     Abstract available


  51. HOFFMANN CJ, Mabuto T, Ginindza S, Fielding KL, et al
    Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation Following HIV Diagnosis: a Randomized Trial.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001428.
    PubMed     Text format     Abstract available


  52. FOGEL JM, Piwowar-Manning E, Debevec B, Walsky T, et al
    Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001421.
    PubMed     Text format     Abstract available


  53. MAHEU-GIROUX M, Vesga JF, Diabate S, Alary M, et al
    Changing dynamics of HIV transmission in Cote d'Ivoire: modeling who acquired and transmitted infections and estimating the impact of past HIV interventions (1976-2015).
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001434.
    PubMed     Text format     Abstract available


  54. POWELL AM, DeVita JM, Ogburu-Ogbonnaya A, Peterson A, et al
    The effect of HIV-centered obstetric care on perinatal outcomes among a cohort of women living with HIV.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001432.
    PubMed     Text format     Abstract available


  55. SACDALAN C, Crowell TA, Colby DJ, Kroon E, et al
    Brief Report: Safety of frequent blood sampling in research participants in an acute HIV infection cohort in Thailand.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001436.
    PubMed     Text format     Abstract available


  56. YEN YF, Jen IA, Chen M, Lan YC, et al
    Human Immunodeficiency Virus Infection Increases the Risk of Incident Psoriasis: A Nationwide Population-based Cohort Study in Taiwan.
    J Acquir Immune Defic Syndr. 2017 Apr 25. doi: 10.1097/QAI.0000000000001431.
    PubMed     Text format     Abstract available


  57. LIU T, Hogan JW, Daniels MJ, Coetzer M, et al
    Improved HIV-1 Viral Load Monitoring Capacity using Pooled Testing with Marker-Assisted Deconvolution.
    J Acquir Immune Defic Syndr. 2017 Apr 25. doi: 10.1097/QAI.0000000000001424.
    PubMed     Text format     Abstract available


  58. BEER L, Mattson CL, Bradley H, Shouse RL, et al
    Trends in ART prescription and viral suppression among HIV-positive young adults in care in the United States, 2009-2013.
    J Acquir Immune Defic Syndr. 2017 Apr 25. doi: 10.1097/QAI.0000000000001427.
    PubMed     Text format     Abstract available


  59. ROSENBERG NE, Graybill LA, Wesevich A, McGrath N, et al
    The Impact of Couple HIV Testing and Counseling on Consistent Condom Use among Pregnant Women and their Male Partners: An Observational Study.
    J Acquir Immune Defic Syndr. 2017 Apr 18. doi: 10.1097/QAI.0000000000001398.
    PubMed     Text format     Abstract available


  60. PUHR R, Kumarasamy N, Ly PS, Ng OT, et al
    HIV and Aging: Demographic Change in the Asia-Pacific Region.
    J Acquir Immune Defic Syndr. 2017;74:e146-e148.
    PubMed     Text format    


  61. GWADZ M, Cleland CM, Perlman DC, Hagan H, et al
    Public Health Benefit of Peer-Referral Strategies for Detecting Undiagnosed HIV Infection Among High-Risk Heterosexuals in New York City.
    J Acquir Immune Defic Syndr. 2017;74:499-507.
    PubMed     Text format     Abstract available


  62. KELLY JD, Reid MJ, Lahiff M, Tsai AC, et al
    Community-level HIV stigma as a driver for HIV transmission risk behaviors and sexually transmitted diseases in Sierra Leone: a population-based study.
    J Acquir Immune Defic Syndr. 2017 Apr 12. doi: 10.1097/QAI.0000000000001418.
    PubMed     Text format     Abstract available


  63. NAIKOBA S, Senjovu KD, Mugabe P, McCarthy C, et al
    Improved HIV and TB knowledge and competence among mid-level providers in a cluster-randomized trial of one-on-one mentorship for task-shifting.
    J Acquir Immune Defic Syndr. 2017 Apr 12. doi: 10.1097/QAI.0000000000001378.
    PubMed     Text format     Abstract available


  64. XIA Q, Zhong Y, Wiewel EW, Braunstein SL, et al
    Linkage to Care after HIV Diagnosis in New York City: Better Than We Thought.
    J Acquir Immune Defic Syndr. 2017 Apr 10. doi: 10.1097/QAI.0000000000001419.
    PubMed     Text format    


  65. PERKINS M, Bradley W, Lalani T, Agan B, et al
    Prevalence of Post-Treatment Controller Phenotype is Rare in HIV-infected Persons after Stopping Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001393.
    PubMed     Text format     Abstract available


  66. DUBROW R, Qin L, Lin H, Hernandez-Ramirez RU, et al
    Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001394.
    PubMed     Text format     Abstract available


  67. RIDOLFO AL, Oreni L, Vassalini P, Resnati C, et al
    Effect of Legal Status on the Early Treatment Outcomes of Migrants Beginning Combined Antiretroviral Therapy at an Outpatient Clinic in Milan Italy.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001388.
    PubMed     Text format     Abstract available


  68. GUERRI-FERNANDEZ R, Molina-Morant D, Villar-Garcia J, Herrera S, et al
    Bone density, microarchitecture and tissue quality following long-term treatment with tenofovir/emtricitabine or abacavir/lamivudine.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001396.
    PubMed     Text format     Abstract available


  69. MONTEJANO R, Stella-Ascariz N, Monge S, Bernardino JI, et al
    Impact of antiretroviral treatment containing tenofovir difumarate on the telomere length of aviremic HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001391.
    PubMed     Text format     Abstract available


  70. CASETTI R, Pinnetti C, Sacchi A, De Simone G, et al
    HIV-specific CD8 T cells producing CCL-4 are associated with worse immune reconstitution during chronic infection.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001392.
    PubMed     Text format     Abstract available


  71. GAIST P, Stirratt MJ
    The Roles of Behavioral and Social Science Research in the Fight against HIV/AIDS: A Functional Framework.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001399.
    PubMed     Text format     Abstract available


  72. MALLAMPATI D, Ford N, Hanaford A, Sugandhi N, et al
    Performance of virological testing for early infant diagnosis: A systematic review.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001387.
    PubMed     Text format     Abstract available


  73. BROWN LB, Ayieko J, Mwangwa F, Owaraganise A, et al
    Predictors of retention in HIV care among youth (15-24) in a universal test-and-treat setting in rural Kenya.
    J Acquir Immune Defic Syndr. 2017 Apr 6. doi: 10.1097/QAI.0000000000001390.
    PubMed     Text format    


  74. SENA AC, Donovan J, Swygard H, Clymore J, et al
    The North Carolina HIV Bridge Counselor Program: outcomes from a statewide level intervention to link and re-engage HIV-infected persons in care in the South.
    J Acquir Immune Defic Syndr. 2017 Apr 6. doi: 10.1097/QAI.0000000000001389.
    PubMed     Text format     Abstract available


  75. PATEL RR, Chan PA, Mena L, Crowley JS, et al
    Time to make the jump: Translating HIV pre-exposure prophylaxis research into real-world public health impact.
    J Acquir Immune Defic Syndr. 2017 Apr 4. doi: 10.1097/QAI.0000000000001386.
    PubMed     Text format    


  76. HOENIGL M, Braun DL, Kouyos R, Gunthard HF, et al
    Evaluation of the Predictive Potential of the Short Acute Retroviral Syndrome Severity Score for HIV-1 Disease Progression in Individuals With Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2017;74:e114-e117.
    PubMed     Text format    


  77. AGSALDA-GARCIA MA, Sithinamsuwan P, Valcour VG, Chalermchai T, et al
    Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr. 2017;74:454-458.
    PubMed     Text format     Abstract available


  78. MARGOLICK JB, Bream JH, Martinez-Maza O, Lopez J, et al
    Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2017;74:407-417.
    PubMed     Text format     Abstract available


  79. CLOUSE K, Vermund SH, Maskew M, Lurie MN, et al
    Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa.
    J Acquir Immune Defic Syndr. 2017;74:383-389.
    PubMed     Text format     Abstract available


  80. PASTOR L, Parker E, Carrillo J, Urrea V, et al
    A Cytokine Pattern That Differentiates Preseroconversion From Postseroconversion Phases of Primary HIV Infection.
    J Acquir Immune Defic Syndr. 2017;74:459-466.
    PubMed     Text format     Abstract available


    March 2017
  81. CUNNINGHAM WE, Ford CL, Kinsler JJ, Seiden D, et al
    Effects of a Laboratory Health Information Exchange Intervention on Antiretroviral Therapy Use, Viral Suppression and Racial/Ethnic Disparities.
    J Acquir Immune Defic Syndr. 2017 Mar 25. doi: 10.1097/QAI.0000000000001385.
    PubMed     Text format     Abstract available


  82. IBRAHIM M, Moyo S, Mohammed T, Mupfumi L, et al
    High Sensitivity and Specificity of the Cepheid Xpert(R) HIV-1 Qualitative Point-of-Care Test among Newborns in Botswana.
    J Acquir Immune Defic Syndr. 2017 Mar 24. doi: 10.1097/QAI.0000000000001384.
    PubMed     Text format     Abstract available


  83. KOELSCH KK, Rasmussen TA, Hey-Nguyen WJ, Pearson C, et al
    Impact of allogeneic hematopoietic stem cell transplantation on the HIV reservoir and immune response in three HIV infected individuals.
    J Acquir Immune Defic Syndr. 2017 Mar 24. doi: 10.1097/QAI.0000000000001381.
    PubMed     Text format     Abstract available


  84. SCRIVEN JE, Graham LM, Schutz C, Scriba TJ, et al
    The CSF immune response in HIV-1-associated cryptococcal meningitis: macrophage activation, correlates of disease severity and effect of antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2017 Mar 24. doi: 10.1097/QAI.0000000000001382.
    PubMed     Text format     Abstract available


  85. MADHAVI V, Kulkarni A, Shete A, Lee WS, et al
    Effect of combination antiretroviral therapy on HIV-1-specific antibody-dependent cellular cytotoxicity responses in subtype B- and subtype C-infected cohorts.
    J Acquir Immune Defic Syndr. 2017 Mar 23. doi: 10.1097/QAI.0000000000001380.
    PubMed     Text format     Abstract available


  86. KELESIDIS T, Oda MN, Borja MS, Yee Y, et al
    Predictors of impaired HDL function in HIV-1 infected compared to uninfected individuals.
    J Acquir Immune Defic Syndr. 2017 Mar 23. doi: 10.1097/QAI.0000000000001383.
    PubMed     Text format     Abstract available


  87. ZHOU RH, Guo L, Liu JB, Liu H, et al
    Epigallocatechin gallate inhibits macaque SEVI-mediated enhancement of SIV or SHIV infection.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001361.
    PubMed     Text format     Abstract available


  88. SIVAY MV, Li M, Piwowar-Manning E, Zhang Y, et al
    Characterization of HIV seroconverters in a TDF/FTC PrEP study: HPTN 067/ADAPT.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001374.
    PubMed     Text format     Abstract available


  89. LEVINE AJ, Martin E, Sacktor N, Munro C, et al
    Predictors and impact of self-reported suboptimal effort on estimates of prevalence of HIV-associated neurocognitive disorders.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001371.
    PubMed     Text format     Abstract available


  90. MUKERJI SS, Misra V, Lorenz D, Cervantes-Arslanian AM, et al
    Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-experienced HIV-1 Infected Adults.
    J Acquir Immune Defic Syndr. 2017 Mar 21. doi: 10.1097/QAI.0000000000001362.
    PubMed     Text format     Abstract available


  91. MAHESWARAN H, Petrou S, MacPherson P, Kumwenda F, et al
    Economic costs and health-related quality of life outcomes of HIV treatment following self- and facility-based HIV testing in a cluster randomised trial.
    J Acquir Immune Defic Syndr. 2017 Mar 21. doi: 10.1097/QAI.0000000000001373.
    PubMed     Text format     Abstract available


  92. MORGAN E, Nyaku AN, D'Aquila RT, Schneider JA, et al
    Determinants of HIV phylogenetic clustering in Chicago among young black men who have sex with men from the uConnect cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001379.
    PubMed     Text format     Abstract available


  93. MERLIN JS, Westfall AO, Heath SL, Goodin BR, et al
    IL-1beta levels are associated with chronic multisite pain in people living with HIV.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001377.
    PubMed     Text format     Abstract available


  94. REID MJ, Baxi SM, Sheira LA, Landay AL, et al
    Higher Body Mass Index is Associated with Greater Proportions of Effector CD8+ T cells Expressing CD57 in Women Living with HIV.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001376.
    PubMed     Text format     Abstract available


  95. CEPEDA JA, Solomon SS, Srikrishnan AK, McFall AM, et al
    Injection drug network characteristics are important markers of HIV risk behavior and lack of viral suppression.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001372.
    PubMed     Text format     Abstract available


  96. LUI G, Ma RC, Chook P, Wong CK, et al
    Progression of Atherosclerosis in HIV-infected Individuals - Prospective Data from an Asian Cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001358.
    PubMed     Text format     Abstract available


  97. NACHEGA JB, Uthman OA, Mofenson LM, Anderson JR, et al
    Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001359.
    PubMed     Text format     Abstract available


  98. TEERAANANCHAI S, Bunupuradah T, Puthanakit T, Kerr SJ, et al
    First line antiretroviral treatment outcomes and durability in HIV-infectedchildren treatedthrough theuniversal coverage health program in Thailand.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001351.
    PubMed     Text format     Abstract available


  99. COELHO LE, Ribeiro SR, Japiassu AM, Moreira RI, et al
    30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001352.
    PubMed     Text format     Abstract available


  100. THOMSON KA, Haberer JE, Marzinke M, Mujugira A, et al
    Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001356.
    PubMed     Text format     Abstract available


  101. TOMITA A, Vandormael AM, Barnighausen T, de Oliveira T, et al
    Social disequilibrium and the risk of HIV acquisition: A multilevel study in rural KwaZulu-Natal Province, South Africa.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001349.
    PubMed     Text format     Abstract available


  102. KAHN J, Xu J, Kapogiannis BG, Sleasman JW, et al
    Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001355.
    PubMed     Text format     Abstract available


  103. KASAIE P, Pennington J, Shah MS, Berry SA, et al
    The Impact of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001354.
    PubMed     Text format     Abstract available


  104. ARRIBAS JR, Thompson M, Sax PE, Haas B, et al
    A Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), Each Coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.
    J Acquir Immune Defic Syndr. 2017 Mar 9. doi: 10.1097/QAI.0000000000001350.
    PubMed     Text format     Abstract available


  105. HALL EW, Ricca AV, Khosropour CM, Sullivan PS, et al
    Capturing HIV incidence among MSM through at-home and self-reported facility-based testing.
    J Acquir Immune Defic Syndr. 2017 Mar 8. doi: 10.1097/QAI.0000000000001338.
    PubMed     Text format    


  106. WOHL DA, Golin CE, Knight K, Gould M, et al
    A Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia Following Prison Release: The imPACT Trial.
    J Acquir Immune Defic Syndr. 2017 Mar 8. doi: 10.1097/QAI.0000000000001337.
    PubMed     Text format     Abstract available


  107. RAFFI F, Orkin C, Clarke A, Slama L, et al
    Long-term (96-week) Efficacy and Safety After Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) in HIV-infected, Virologically Suppressed Adults.
    J Acquir Immune Defic Syndr. 2017 Mar 6. doi: 10.1097/QAI.0000000000001344.
    PubMed     Text format     Abstract available


  108. LACOMBE K, Fontaine H, Dhiver C, Metivier S, et al
    Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Co-Infected Patients With Advanced Liver Disease in a French Early-Access Cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 6. doi: 10.1097/QAI.0000000000001342.
    PubMed     Text format     Abstract available


  109. VAN HANDEL MM, Brooks JT
    Reply.
    J Acquir Immune Defic Syndr. 2017;74:e84-e85.
    PubMed     Text format    


  110. BOYLES TH, Gatley E, Wasserman S, Meintjes G, et al
    Brief Report: Flow Rate of Cerebrospinal Fluid Through a Spinal Needle Can Accurately Predict Intracranial Pressure in Cryptococcal Meningitis.
    J Acquir Immune Defic Syndr. 2017;74:e64-e66.
    PubMed     Text format     Abstract available


  111. LIEBENBERG LJ, Masson L, Arnold KB, Mckinnon LR, et al
    Genital-Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women.
    J Acquir Immune Defic Syndr. 2017;74:318-325.
    PubMed     Text format     Abstract available


  112. PARSONS JT, Rendina HJ, Lassiter JM, Whitfield TH, et al
    Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States.
    J Acquir Immune Defic Syndr. 2017;74:285-292.
    PubMed     Text format     Abstract available


    February 2017
  113. CARLUCCI JG, Blevins M, Kipp AM, Lindegren ML, et al
    Tuberculosis Treatment Outcomes among HIV/TB Co-Infected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001335.
    PubMed     Text format     Abstract available


  114. HERNANDEZ S, Catalan-Garcia M, Moren C, Garcia-Otero L, et al
    Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis And Adverse Perinatal Outcomes In Hiv-Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001334.
    PubMed     Text format     Abstract available


  115. MUSARANDEGA R, Machekano R, Chideme M, Muchuchuti C, et al
    PMTCT Service Uptake among Adolescents and Adult Women Attending Antenatal Care in Selected Health Facilities in Zimbabwe.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001327.
    PubMed     Text format     Abstract available


  116. RAY N, Li T, Lin Z, Protack T, et al
    The second-generation maturation inhibitor GSK3532795 maintains potent activity toward HIV protease inhibitor-resistant clinical isolates.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001304.
    PubMed     Text format     Abstract available


  117. HELMUT A, Dillingham R, Hogg RS, Jaworsky D, et al
    The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.
    J Acquir Immune Defic Syndr. 2017 Feb 16. doi: 10.1097/QAI.0000000000001329.
    PubMed     Text format     Abstract available


  118. XIA Q, Sun X, Wiewel EW, Torian LV, et al
    HIV Prevalence and the Prevalence of Unsuppressed HIV in New York City, 2010-2014.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001311.
    PubMed     Text format     Abstract available


  119. SINGH D, Ghate M, Godbole S, Kulkarni S, et al
    CD1d restricted Natural killer T cells are preserved in Indian long term non progressors (LTNPs).
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001322.
    PubMed     Text format     Abstract available


  120. MACATANGAY BJ, Yang M, Sun X, Morton J, et al
    Changes in Levels of Inflammation Following Antiretroviral Treatment During Early HIV Infection in ACTG A5217.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001320.
    PubMed     Text format     Abstract available


  121. BRUNET L, Napravnik S, Heine AD, Leone PA, et al
    Longitudinal opioid use among HIV-infected patients, 2000 to 2014.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001321.
    PubMed     Text format     Abstract available


  122. HAALAND RE, Holder A, Pau CP, Swaims-Kohlmeier A, et al
    Levels of intracellular phosphorylated tenofovir and emtricitabine correlate with natural substrate concentrations in peripheral blood mononuclear cells of persons prescribed daily oral TruvadaTM for HIV pre-exposure prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001324.
    PubMed     Text format    


  123. GALLANT JE, Thompson M, DeJesus E, Voskuhl GW, et al
    Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults.
    J Acquir Immune Defic Syndr. 2017 Feb 8. doi: 10.1097/QAI.0000000000001306.
    PubMed     Text format     Abstract available


  124. GIRARD A, Jelicic K, Van Ryk D, Rochereau N, et al
    The neutralizing and targeting properties of a new set of alpha4beta7-specific antibodies are influenced by their isotype.
    J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001307.
    PubMed     Text format     Abstract available


  125. KESSING CF, Spudich S, Valcour V, Cartwright P, et al
    High Number of Activated CD8+ T Cells Targeting HIV Antigens are Present in Cerebrospinal Fluid in Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001301.
    PubMed     Text format     Abstract available


  126. O'NEILL TJ, Raboud JM, Tinmouth J, Rourke SB, et al
    Gastrointestinal Symptom Distress is Associated with Worse Mental and Physical Health Related Quality of Life.
    J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001309.
    PubMed     Text format     Abstract available


  127. TENFORDE MW, Yadav A, Dowdy DW, Gupte N, et al
    Vitamin A and D deficiencies associated with incident tuberculosis in HIV-infected patients initiating antiretroviral therapy in multinational case-cohort study.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001308.
    PubMed     Text format     Abstract available


  128. BRAHMBHATT H, Boivin M, Ssempijja V, Kagaayi J, et al
    Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School Aged Children.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001305.
    PubMed     Text format     Abstract available


  129. LYONS C, Ketende S, Drame F, Grosso A, et al
    Physical and sexual violence affecting female sex workers in Abidjan, Cote d'Ivoire: Prevalence, and the relationship between violence, the work environment, HIV and access to health services.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001310.
    PubMed     Text format     Abstract available


  130. WOHL AR, Ludwig-Barron N, Dierst-Davies R, Kulkarni S, et al
    Project Engage: Snowball Sampling and Direct Recruitment to Identify and Link Hard-to-Reach HIV-Infected Persons who are Out of Care.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001312.
    PubMed     Text format     Abstract available


  131. YOUNG SD, Yu W, Wang W
    Toward Automating HIV Identification: Machine Learning for Rapid Identification of HIV-Related Social Media Data.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S128-S131.
    PubMed     Text format     Abstract available


  132. SENN TE, Braksmajer A, Coury-Doniger P, Urban MA, et al
    Development and Preliminary Pilot Testing of a Peer Support Text Messaging Intervention for HIV-Infected Black Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S121-S127.
    PubMed     Text format     Abstract available


  133. COLASANTI J, Stahl N, Farber EW, Del Rio C, et al
    An Exploratory Study to Assess Individual and Structural Level Barriers Associated With Poor Retention and Re-engagement in Care Among Persons Living With HIV/AIDS.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S113-S120.
    PubMed     Text format     Abstract available


  134. DOLWICK GRIEB SM, Flores-Miller A, Page KR
    inverted exclamation markSolo Se Vive Una Vez! (You Only Live Once): A Pilot Evaluation of Individually Tailored Video Modules Aiming to Increase HIV Testing Among Foreign-Born Latino Men.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S104-S112.
    PubMed     Text format     Abstract available


  135. CASTEL AD, Kuo I, Mikre M, Young T, et al
    Feasibility of Using HIV Care-Continuum Outcomes to Identify Geographic Areas for Targeted HIV Testing.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S96-S103.
    PubMed     Text format     Abstract available


  136. POWERS KA, Samoff E, Weaver MA, Sampson LA, et al
    Longitudinal HIV Care Trajectories in North Carolina.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S88-S95.
    PubMed     Text format     Abstract available


  137. DOMBROWSKI JC, Bove J, Roscoe JC, Harvill J, et al
    "Out of Care" HIV Case Investigations: A Collaborative Analysis Across 6 States in the Northwest US.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S81-S87.
    PubMed     Text format     Abstract available


  138. GREENBERG AE, Gordon CM, Purcell DW
    Promotion of Research on the HIV Continuum of Care in the United States: The CFAR HIV Continuum of Care/ECHPP Working Group.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S75-S80.
    PubMed     Text format    


  139. SCHNELL KM, Atta MG, Fine DM, Zook K, et al
    Longitudinal assessment of proximal tubular dysfunction in HIV seropositive and seronegative persons: correlates and implications.
    J Acquir Immune Defic Syndr. 2017 Feb 1. doi: 10.1097/QAI.0000000000001302.
    PubMed     Text format     Abstract available


    January 2017
  140. GOEIEMAN BJ, Firnhaber CS, Jong E, Michelow P, et al
    Prevalence Of Anal Hpv And Anal Dysplasia In Hiv-Infected Women From Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001300.
    PubMed     Text format     Abstract available


  141. LACOURSE SM, Cranmer LM, Matemo D, Kinuthia J, et al
    Effect of pregnancy on interferon gamma release-assay and tuberculin skin test detection of latent TB infection among HIV-infected women in a high burden setting.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001298.
    PubMed     Text format     Abstract available


  142. RUBIN LH, Phan KL, Keating SM, Weber KM, et al
    Low dose hydrocortisone has acute enhancing effects on verbal learning in HIV-infected men.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001303.
    PubMed     Text format     Abstract available


  143. FELSEN UR, Cunningham CO, Heo M, Futterman DC, et al
    An expanded HIV testing strategy leveraging the electronic medical record uncovers undiagnosed infection among hospitalized patients.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001299.
    PubMed     Text format     Abstract available


  144. WALKER JA, Miller AD, Burdo TH, McGrath MS, et al
    Direct Targeting of Macrophages with Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001297.
    PubMed     Text format     Abstract available


  145. DE LA MATA NL, Ly PS, Van Nguyen K, Merati TP, et al
    Loss to follow-up trends in HIV-positive patients receiving antiretroviral treatment in Asia from 2003 to 2013.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001293.
    PubMed     Text format     Abstract available


  146. SAPHONN V, Fujita M, Samreth S, Chan S, et al
    Cluster of HIV Infections Associated with Unsafe Injection Practices in a Rural Village in Cambodia.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001295.
    PubMed     Text format    


  147. SANFORD R, Fernandez Cruz AL, Scott SC, Mayo NE, et al
    Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-infected Patients in the HAART era.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001294.
    PubMed     Text format     Abstract available


  148. KITYO C, Thompson J, Nankya I, Hoppe A, et al
    HIV drug resistance mutations in non-B subtypes after prolonged virological failure on NNRTI-based first-line regimens in sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001285.
    PubMed     Text format     Abstract available


  149. LAU E, Brophy J, Samson L, Kakkar F, et al
    Nevirapine Pharmacokinetics and Safety in Neonates Receiving Combination Antiretroviral Therapy for Prevention of Vertical HIV Transmission.
    J Acquir Immune Defic Syndr. 2017 Jan 20. doi: 10.1097/QAI.0000000000001291.
    PubMed     Text format     Abstract available


  150. BEIMA-SOFIE KM, Brandt L, Hamunime N, Shepard M, et al
    Pediatric HIV disclosure intervention improves knowledge and clinical outcomes in HIV-infected children in Namibia.
    J Acquir Immune Defic Syndr. 2017 Jan 20. doi: 10.1097/QAI.0000000000001290.
    PubMed     Text format     Abstract available


  151. COUDERC C, Keita BD, Anoma C, Wade AS, et al
    Is PrEP needed for MSM in West Africa? HIV incidence in a prospective multi-country cohort.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001288.
    PubMed     Text format    


  152. MASIA M, Padilla S, Fernandez M, Barber X, et al
    Contribution of oxidative stress to non-AIDS events in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001287.
    PubMed     Text format     Abstract available


  153. WOLDESENBET S, Jackson DJ, Lombard CJ, Dinh TH, et al
    Structural Level Differences in the Mother-to-Child HIV Transmission Rate in South Africa: A Multilevel Assessment of Individual-, Health facility-, and Provincial- Level Predictors of Infant HIV Transmission.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001289.
    PubMed     Text format     Abstract available


  154. OKUKU F, Krantz EM, Kafeero J, Kamya MR, et al
    Evaluation of a predictive staging model for HIV-associated Kaposi sarcoma in Uganda.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001286.
    PubMed     Text format     Abstract available


  155. TUMINO N, Bilotta MT, Pinnetti C, Ammassari A, et al
    Granulocytic Myeloid Derived Suppressor Cells increased in early phases of primary HIV infection depending on TRAIL plasma level.
    J Acquir Immune Defic Syndr. 2017 Jan 2. doi: 10.1097/QAI.0000000000001283.
    PubMed     Text format     Abstract available


  156. ORR N, Hajiyiannis H, Myers L, Makhubele MB, et al
    Development of a National Campaign Addressing South African Men's Fears About HIV Counseling and Testing and Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S69-S73.
    PubMed     Text format     Abstract available


  157. KERRIGAN D, Mbwambo J, Likindikoki S, Beckham S, et al
    Project Shikamana: Baseline Findings From a Community Empowerment-Based Combination HIV Prevention Trial Among Female Sex Workers in Iringa, Tanzania.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S60-S68.
    PubMed     Text format     Abstract available


  158. LYONS CE, Ketende S, Diouf D, Drame FM, et al
    Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S52-S59.
    PubMed     Text format     Abstract available


  159. LIPPMAN SA, Neilands TB, MacPhail C, Peacock D, et al
    Community Mobilization for HIV Testing Uptake: Results From a Community Randomized Trial of a Theory-Based Intervention in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S44-S51.
    PubMed     Text format     Abstract available


  160. HIRSCH-MOVERMAN Y, Daftary A, Yuengling KA, Saito S, et al
    Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S37-S43.
    PubMed     Text format     Abstract available


  161. SUTTON R, Lahuerta M, Abacassamo F, Ahoua L, et al
    Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S29-S36.
    PubMed     Text format     Abstract available


  162. MABUTO T, Charalambous S, Hoffmann CJ
    Effective Interpersonal Health Communication for Linkage to Care After HIV Diagnosis in South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S23-S28.
    PubMed     Text format     Abstract available


  163. MORTON JF, Celum C, Njoroge J, Nakyanzi A, et al
    Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S15-S22.
    PubMed     Text format     Abstract available


  164. BABALOLA S, Van Lith LM, Mallalieu EC, Packman ZR, et al
    A Framework for Health Communication Across the HIV Treatment Continuum.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S5-S14.
    PubMed     Text format     Abstract available


  165. VERMUND SH, Mallalieu EC, Van Lith LM, Struthers HE, et al
    Health Communication and the HIV Continuum of Care.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S1-S4.
    PubMed     Text format     Abstract available


  166. SEGHATOL-ESLAMI VC, Dark HE, Raper JL, Mugavero MJ, et al
    Brief Report: Interpersonal and Intrapersonal Factors as Parallel Independent Mediators in the Association Between Internalized HIV Stigma and ART Adherence.
    J Acquir Immune Defic Syndr. 2017;74:e18-e22.
    PubMed     Text format     Abstract available


  167. ROSENBERG MS, Gomez-Olive FX, Rohr JK, Houle BC, et al
    Sexual Behaviors and HIV Status: A Population-Based Study Among Older Adults in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;74:e9-e17.
    PubMed     Text format     Abstract available


  168. ORR N, Hajiyiannis H, Myers L, Makhubele MB, et al
    Development of a National Campaign Addressing South African Men's Fears About HIV Counseling and Testing and Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S69-S73.
    PubMed     Text format     Abstract available


  169. KERRIGAN D, Mbwambo J, Likindikoki S, Beckham S, et al
    Project Shikamana: Baseline Findings From a Community Empowerment-Based Combination HIV Prevention Trial Among Female Sex Workers in Iringa, Tanzania.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S60-S68.
    PubMed     Text format     Abstract available


  170. LYONS CE, Ketende S, Diouf D, Drame FM, et al
    Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S52-S59.
    PubMed     Text format     Abstract available


  171. LIPPMAN SA, Neilands TB, MacPhail C, Peacock D, et al
    Community Mobilization for HIV Testing Uptake: Results From a Community Randomized Trial of a Theory-Based Intervention in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S44-S51.
    PubMed     Text format     Abstract available


  172. HIRSCH-MOVERMAN Y, Daftary A, Yuengling KA, Saito S, et al
    Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S37-S43.
    PubMed     Text format     Abstract available


  173. SUTTON R, Lahuerta M, Abacassamo F, Ahoua L, et al
    Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S29-S36.
    PubMed     Text format     Abstract available


  174. MABUTO T, Charalambous S, Hoffmann CJ
    Effective Interpersonal Health Communication for Linkage to Care After HIV Diagnosis in South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S23-S28.
    PubMed     Text format     Abstract available


  175. MORTON JF, Celum C, Njoroge J, Nakyanzi A, et al
    Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S15-S22.
    PubMed     Text format     Abstract available


  176. BABALOLA S, Van Lith LM, Mallalieu EC, Packman ZR, et al
    A Framework for Health Communication Across the HIV Treatment Continuum.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S5-S14.
    PubMed     Text format     Abstract available


  177. VERMUND SH, Mallalieu EC, Van Lith LM, Struthers HE, et al
    Health Communication and the HIV Continuum of Care.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S1-S4.
    PubMed     Text format     Abstract available


    December 2016
  178. BASSETT IV, Coleman SM, Giddy J, MFamMed, et al
    Barriers to care and 1-year mortality among newly-diagnosed HIV-infected people in Durban, South Africa.
    J Acquir Immune Defic Syndr. 2016 Dec 30. doi: 10.1097/QAI.0000000000001277.
    PubMed     Text format     Abstract available


  179. GOYETTE MS, Wilson KS, Deya R, Masese LN, et al
    Association between menopause and unprotected sex in high-risk HIV-positive women in Mombasa, Kenya.
    J Acquir Immune Defic Syndr. 2016 Dec 30. doi: 10.1097/QAI.0000000000001282.
    PubMed     Text format     Abstract available


  180. HILEMAN CO, Tangpricha V, Sattar A, McComsey GA, et al
    Baseline vitamin D deficiency decreases the effectiveness of statins in HIV-infected adults on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2016 Dec 29. doi: 10.1097/QAI.0000000000001281.
    PubMed     Text format     Abstract available


  181. KILLIAN MS, Fujimura SH, Sudhagoni RG
    Increased Expression of the Type I Interferon Receptor on CD4+ T Lymphocytes in HIV-1 Infected Individuals.
    J Acquir Immune Defic Syndr. 2016 Dec 22. doi: 10.1097/QAI.0000000000001280.
    PubMed     Text format     Abstract available


  182. WEINBERGER AH, Smith PH, Funk AP, Rabin S, et al
    Gender differences in tobacco use among persons living with HIV/AIDS: A systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2016 Dec 20. doi: 10.1097/QAI.0000000000001279.
    PubMed     Text format     Abstract available


  183. WEISER J, Brooks JT, Skarbinski J, West BT, et al
    Barriers to Universal Prescribing of Antiretroviral Therapy by HIV Care Providers in the United States, 2013-2014.
    J Acquir Immune Defic Syndr. 2016 Dec 17. doi: 10.1097/QAI.0000000000001276.
    PubMed     Text format     Abstract available


  184. SCHMITZ ME, Agolory S, Junghae M, Broyles LN, et al
    Field evaluation of Dried Blood Spots for HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Kenya: Implications for scale-up in resource-limited settings.
    J Acquir Immune Defic Syndr. 2016 Dec 17. doi: 10.1097/QAI.0000000000001275.
    PubMed     Text format     Abstract available


  185. HOTTON AL, Weber KM, Hershow RC, Anastos K, et al
    Prevalence and predictors of hospitalizations among HIV-Infected and at-risk HIV-Uninfected Women.
    J Acquir Immune Defic Syndr. 2016 Dec 17. doi: 10.1097/QAI.0000000000001278.
    PubMed     Text format     Abstract available


  186. LANE T, Osmand T, Marr A, Struthers H, et al
    Brief Report: High HIV Incidence in a South African Community of Men Who Have Sex With Men: Results From the Mpumalanga Men's Study, 2012-2015.
    J Acquir Immune Defic Syndr. 2016;73:609-611.
    PubMed     Text format     Abstract available


  187. MARCUS JL, Hurley LB, Hare CB, Nguyen DP, et al
    Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.
    J Acquir Immune Defic Syndr. 2016;73:540-546.
    PubMed     Text format     Abstract available


  188. GILLIS J, Loutfy M, Bayoumi AM, Antoniou T, et al
    A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016;73:531-539.
    PubMed     Text format     Abstract available


  189. BOCK P, James A, Nikuze A, Peton N, et al
    Baseline CD4 Count and Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2016;73:514-521.
    PubMed     Text format     Abstract available


  190. WAGNER AD, Mugo C, Njuguna IN, Maleche-Obimbo E, et al
    Implementation and Operational Research: Active Referral of Children of HIV-Positive Adults Reveals High Prevalence of Undiagnosed HIV.
    J Acquir Immune Defic Syndr. 2016;73:e83-e89.
    PubMed     Text format     Abstract available


  191. HANSCOM B, Janes HE, Guarino PD, Huang Y, et al
    Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence.
    J Acquir Immune Defic Syndr. 2016;73:606-608.
    PubMed     Text format     Abstract available


  192. MOORE CL, Grulich AE, Prestage G, Gidding HF, et al
    Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.
    J Acquir Immune Defic Syndr. 2016;73:589-597.
    PubMed     Text format     Abstract available


  193. DAVIS NL, Miller WC, Hudgens MG, Chasela CS, et al
    Maternal and Breastmilk Viral Load: Impacts of Adherence on Peripartum HIV Infections Averted-The Breastfeeding, Antiretrovirals, and Nutrition Study.
    J Acquir Immune Defic Syndr. 2016;73:572-580.
    PubMed     Text format     Abstract available


  194. GAMELL A, Glass TR, Luwanda LB, Mapesi H, et al
    Implementation and Operational Research: An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.
    J Acquir Immune Defic Syndr. 2016;73:e67-e75.
    PubMed     Text format     Abstract available


  195. PECK RN, Wang RJ, Mtui G, Smart L, et al
    Linkage to Primary Care and Survival After Hospital Discharge for HIV-Infected Adults in Tanzania: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2016;73:522-530.
    PubMed     Text format     Abstract available


  196. VOGT F, Rehman AM, Kranzer K, Nyathi M, et al
    Relationship between time to initiation of antiretroviral therapy and treatment outcomes: a cohort analysis of ART eligible adolescents in Zimbabwe.
    J Acquir Immune Defic Syndr. 2016 Dec 15. doi: 10.1097/QAI.0000000000001274.
    PubMed     Text format     Abstract available


  197. CATALDO F, Chiwaula L, Nkhata M, van Lettow M, et al
    Exploring the experiences of women and health care workers in the context of PMTCT Option B Plus in Malawi.
    J Acquir Immune Defic Syndr. 2016 Dec 9. doi: 10.1097/QAI.0000000000001273.
    PubMed     Text format     Abstract available


  198. LUCIA P, Erica P, Jorge C, Victor U, et al
    A cytokine pattern that differentiates pre- from post- seroconversion phases of primary HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  199. FETTIPLACE A, Stainsby C, Winston A, Givens N, et al
    Psychiatric Symptoms in Patients Receiving Dolutegravir.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  200. NAGAO A, Hanabusa H
    The impact of ledipasvir/sofosbuvir on HIV-positive and HIV-negative Japanese hemophilia patients with 1, 4, and mixed-genotype HCV.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  201. DEREN S, Cleland CM, Lee H, Mehandru S, et al
    The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune Activation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  202. KENDALL CE, Chalifoux M, Manuel D, Reinhard R, et al
    A population-based study of care at the end of life among people with HIV in Ontario from 2010 to 2013.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  203. FORD D, Muzambi M, Nkhata MJ, Abongomera G, et al
    Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  204. KHOSROPOUR CM, Dombrowski JC, Kerani RP, Katz DA, et al
    Changes in Condomless Sex and Serosorting Among Men Who Have Sex With Men After HIV Diagnosis.
    J Acquir Immune Defic Syndr. 2016;73:475-481.
    PubMed     Text format     Abstract available


  205. CHIU A, Modi S, Rivadeneira ED, Koumans EH, et al
    Optimizing Infant HIV Diagnosis in Resource-Limited Settings: Modeling the Impact of HIV DNA PCR Testing at Birth.
    J Acquir Immune Defic Syndr. 2016;73:454-462.
    PubMed     Text format     Abstract available


  206. SHARMA A, Ma Y, Scherzer R, Wheeler AL, et al
    Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected Women.
    J Acquir Immune Defic Syndr. 2016;73:433-437.
    PubMed     Text format     Abstract available


  207. PELTENBURG NC, Leers MP, Bakker JA, Lowe SH, et al
    Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016;73:390-395.
    PubMed     Text format     Abstract available


  208. SONG R, Pace C, Seaman MS, Fang Q, et al
    Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies.
    J Acquir Immune Defic Syndr. 2016;73:365-373.
    PubMed     Text format     Abstract available


  209. DIERKS P, Wroblewski R, Eberhard JM, Martrus G, et al
    Increased frequency of CD39+ CD56 bright Natural Killer cells in HIV-1 infection correlates with immune activation and disease progression.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  210. COWAN FM, Davey C, Fearon E, Mushati P, et al
    The HIV care cascade among female sex workers in Zimbabwe: results of a population-based survey from the Sisters Antiretroviral therapy Programme for Prevention of HIV, an Integrated Response (SAPPH-IRe) Trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


    November 2016
  211. VAN HANDEL MM, Brooks JT
    Understanding local context is necessary for HIV and HCV prevention planning.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  212. WOMACK JA, Murphy TE, Bathulapalli H, Akgun KM, et al
    Sleep Disturbance Among HIV Infected and Uninfected Veterans.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  213. MARZEL A, Heinrich H, Schilliger L, Fehr JS, et al
    Prescription of Post-Exposure Prophylaxis for HIV-1 in the emergency room: Correct transmission risk assessment remains challenging.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  214. ABDEL-HAMEED EA, Rouster SD, Zhang X, Chen J, et al
    Characterization of HCV NS3 Protease Variants in HCV/HIV Coinfected Patients by Ultra-deep Sequence Analysis: Relationship to Hepatic Fibrosis.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  215. PARSONS JT, Rendina HJ, Lassiter JM, Whitfield TH, et al
    Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States: The Motivational PrEP Cascade.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  216. CHAGOMERANA MB, Miller WC, Pence BW, Hosseinipour MC, et al
    PMTCT Option B+ does not increase preterm birth risk and may prevent extreme prematurity: A retrospective cohort study in Malawi.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  217. CHOW FC, Li Y, Hu Y, Chan J, et al
    Relationship between HIV infection, antiretroviral therapy, inflammatory markers and cerebrovascular endothelial function among adults in urban China.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  218. CAMLIN CS, Ayadi AM, Kwena ZA, McFarland W, et al
    High Mobility and HIV Prevalence among Female Market Traders in East Africa in 2014.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  219. DAVEY DJ, Beymer M, Roberts CP, Bolan RK, et al
    Differences in Risk Behavior and Demographic Factors between Men who have Sex with Men with Acute and Non-Acute Human Immunodeficiency Virus Infection in a Community-Based Testing Program in Los Angeles.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  220. SAKODA ME, Fazeli PL, Ellis RJ, Jeste DV, et al
    Higher cystatin C levels are associated with neurocognitive impairment in older HIV+ adults.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  221. PROTOPOPESCU C, Carrieri MP, Raffi F, Picard O, et al
    Prolonged viral suppression over a 12-year follow-up of HIV-infected patients: the persistent impact of adherence at 4 months after initiation of combined antiretroviral therapy in the ANRS CO8 APROCO-COPILOTE cohort.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  222. MENDOZA C, Barrington C, Donastorg Y, Perez M, et al
    Violence from a Sexual Partner is Significantly Associated with Poor HIV Care and Treatment Outcomes among Female Sex Workers in the Dominican Republic.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  223. KORHONEN C, Srinivasan S, Huang D, Ko DL, et al
    Semen Bacterial Concentrations and HIV-1 RNA Shedding among HIV-1-Seropositive Kenyan Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  224. GO VF, Frangakis C, Le Minh N, Ha TV, et al
    Increased survival among HIV-infected PWID receiving a multi-level HIV risk and stigma reduction intervention: results from a randomized controlled trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  225. KAMENJU P, Liu E, Hertzmark E, Spiegelman D, et al
    Complementary Feeding and Diarrhea and Respiratory Infection Among HIV-exposed Tanzanian Infants.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  226. TURNER CM, Santos GM, Arayasirikul S, Wilson EC, et al
    Psychosocial predictors of engagement in sexual risk behavior among trans*female youth ages 16 - 24 years in San Francisco.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  227. DOBLECKI-LEWIS S, Liu A, Feaster D, Cohen SE, et al
    Healthcare Access and PrEP Continuation in San Francisco and Miami Following the U.S. PrEP Demo Project.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  228. FIDLER S, Olson AD, Bucher HC, Fox J, et al
    Virological blips and predictors of post treatment viral control after stopping ART started in Primary HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  229. BRUZZONE B, Caligiuri P, Nigro N, Arcuri C, et al
    In response to Gueudin et al.: Xpert(R) HIV-1 Viral Load assay and VERSANT(R) HIV-1 RNA 1.5 Assay, a performance comparison.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  230. KOSS CA, Natureeba P, Kwarisiima D, Ogena M, et al
    Viral Suppression and Retention in Care up to 5 Years after Initiation of Lifelong ART during Pregnancy (Option B+) in Rural Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  231. AL-KINDI SG, Kim CH, Morris SR, Freeman ML, et al
    Elevated Red Cell Distribution Width (RDW) Identifies Elevated Cardiovascular Disease Risk in Patients with HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  232. MONTEIRO DE ALMEIDA S, Kamat R, Cherner M, Umlauf A, et al
    Improving detection of HIV-associated cognitive impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  233. VITA S, Lichtner M, Marchetti G, Mascia C, et al
    Soluble CD163 in CMV Infected and Uninfected subjects on Virologically-Suppressive Antiretroviral therapy in the ICONA cohort.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  234. MONTOYA JL, Iudicello J, Fazeli PL, Hong S, et al
    Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated with Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  235. KINUTHIA J, Richardson BA, Drake AL, Matemo D, et al
    Sexual Behavior and Vaginal Practices during Pregnancy and Postpartum: Implications for HIV Prevention Strategies.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  236. FOGEL JM, Clarke W, Kulich M, Piwowar-Manning E, et al
    Antiretroviral drug use in a cross-sectional population survey in Africa: NIMH Project Accept (HPTN 043).
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  237. FOX J, Tiraboschi JM, Herrera C, Else L, et al
    Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2016;73:252-257.
    PubMed     Text format     Abstract available


  238. XIA Q, Lazar R, Bernard MA, McNamee P, et al
    New York City Achieves the UNAIDS 90-90-90 Targets for HIV-Infected Whites but Not Latinos/Hispanics and Blacks.
    J Acquir Immune Defic Syndr. 2016;73:e59-e62.
    PubMed     Text format    


  239. HAINES CF, Fleishman JA, Yehia BR, Lau B, et al
    Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities.
    J Acquir Immune Defic Syndr. 2016;73:340-347.
    PubMed     Text format     Abstract available


  240. VAN HANDEL MM, Rose CE, Hallisey EJ, Kolling JL, et al
    County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.
    J Acquir Immune Defic Syndr. 2016;73:323-331.
    PubMed     Text format     Abstract available


  241. LUDEMA C, Cole SR, Eron JJ Jr, Edmonds A, et al
    Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.
    J Acquir Immune Defic Syndr. 2016;73:307-312.
    PubMed     Text format     Abstract available


  242. KARITA E, Nsanzimana S, Ndagije F, Wall KM, et al
    Implementation and Operational Research: Evolution of Couples' Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice.
    J Acquir Immune Defic Syndr. 2016;73:e51-e58.
    PubMed     Text format     Abstract available


  243. SSEMMONDO E, Mwangwa F, Kironde JL, Kwarisiima D, et al
    Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda.
    J Acquir Immune Defic Syndr. 2016;73:e46-e50.
    PubMed     Text format     Abstract available


  244. CHANG W, Chamie G, Mwai D, Clark TD, et al
    Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa.
    J Acquir Immune Defic Syndr. 2016;73:e39-e45.
    PubMed     Text format     Abstract available


    October 2016
  245. SCHEIM AI, Bauer GR, Travers R
    HIV-related sexual risk among transgender men who are gay, bisexual, or have sex with men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  246. TAYLOR N, Kremser I, Auer S, Hoermann G, et al
    Hemeoxygenase-1 as a novel driver in ritonavir-induced insulin resistance in HIV-1-infected patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  247. SHEPHERD BE, Rebeiro PF
    Assessing and interpreting the association between continuous covariates and outcomes in observational studies of HIV using splines.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  248. YEN YF, Chen M, Jen I, Lan YC, et al
    Association of HIV and Opportunistic Infections with Incident Stroke: A Nationwide Population-based Cohort Study in Taiwan.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  249. LIEBENBERG LJ, Masson L, Arnold KB, Mckinnon LR, et al
    Genital - Systemic chemokine gradients and the risk of HIV acquisition in women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  250. CHOI KH, Steward WT, Miege P, Gregorich SE, et al
    Unpacking the Influence of Sexual Stigma on HIV Risk: Results from a Prospective Study of Men Who Have Sex with Men in Beijing, China.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  251. VOGT F, Kalenga L, Lukela J, Salumu F, et al
    Decentralizing ART supply for stable HIV patients to community-based distribution centres: Programme outcomes from an urban context in Kinshasa, DRC.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  252. YOTEBIENG M, Moracco KE, Thirumurthy H, Edmonds A, et al
    Conditional cash transfers improve retention in PMTCT services by mitigating the negative effect of not having money to come to the clinic.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  253. GOMEZ-MORA E, Robert-Hebmann V, Garcia E, Massanella M, et al
    Impaired CD4 T-cell response to autophagy in treated HIV-1-infected individuals.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  254. EATON EF, Hudak K, Muzny CA
    Budgetary Impact of Compliance with STI Screening Guidelines in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  255. HARRIS RA, Xue X, Selwyn PA
    Housing Stability and Medication Adherence among HIV-Positive Individuals in Antiretroviral Therapy: A Meta-Analysis of Observational Studies in the U.S.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  256. BAXI SM, Scherzer R, Jotwani V, Estrella MM, et al
    Changes in Urinary Biomarkers over 10 Years is Associated with Viral Suppression in a Prospective Cohort of Women Living with HIV.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  257. KOURTIS AP, Wiener J, King CC, Heffron R, et al
    Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-infected African women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  258. PIRONTI A, Walter H, Pfeifer N, Knops E, et al
    Determination of Phenotypic Resistance Cutoffs from Routine Clinical Data.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  259. HUHN GD, Tebas P, Gallant J, Wilkin T, et al
    A Randomized , Open-label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide plus Darunavir in Treatment-Experienced HIV-1 Infected Adults.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  260. MANHICA I, Bhatt N, Ismael N, Nhavene E, et al
    First report of prevalence of HTLV-1 among HIV-1/2 infected children in Mozambique.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  261. WINSTON A, Stohr W, Antinori A, Amieva H, et al
    Changes in Cognitive Function Over 96 weeks in Naive Patients Randomised to Darunavir-ritonavir plus either Raltegravir or Tenofovir-Emtricitabine: a substudy of the NEAT001/ANRS143 trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  262. SATRE DD, Altschuler A, Parthasarathy S, Silverberg MJ, et al
    Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  263. BALLEGAARD V, Ralfkiaer U, Pedersen KK, Hove M, et al
    MicroRNA-210, microRNA-331 and microRNA-7 are differentially regulated in treated HIV-1-infected individuals, and are associated with markers of systemic inflammation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  264. SHI B, Li J, Shi X, Jia W, et al
    TALEN-mediated knockout of CCR5 confers protection against infection of human immunodeficiency virus.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  265. JOSEPH DAVEY D, Nhavoto JA, Augusto O, Ponce W, et al
    SMSaude: Evaluating Mobile Phone Text Reminders to Improve Retention in HIV Care for Patients on Antiretroviral Therapy in Mozambique.
    J Acquir Immune Defic Syndr. 2016;73:e23-30.
    PubMed     Text format     Abstract available


  266. RANSOME Y, Galea S, Pabayo R, Kawachi I, et al
    Social Capital is Associated With Late HIV Diagnosis: An Ecological Analysis.
    J Acquir Immune Defic Syndr. 2016;73:213-21.
    PubMed     Text format     Abstract available


  267. BASSETT IV, Coleman SM, Giddy J, Bogart LM, et al
    Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa.
    J Acquir Immune Defic Syndr. 2016;73:154-60.
    PubMed     Text format     Abstract available


  268. STIKSRUD B, Lorvik KB, Kvale D, Mollnes TE, et al
    Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts.
    J Acquir Immune Defic Syndr. 2016;73:138-48.
    PubMed     Text format     Abstract available


    September 2016
  269. LEE SK, Zhou S, Baldoni PL, Spielvogel E, et al
    Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID In A Viral Outgrowth Assay.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  270. POST FA, Tebas P, Clarke A, Cotte L, et al
    Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  271. BOYLES TH, Gately E, Wasserman S, Meintjes G, et al
    Flow rate of CSF through a spinal needle can accurately predict intracranial pressure in cryptococcal meningitis.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  272. BACON O, Gonzalez R, Andrew E, Potter MB, et al
    Informing Strategies to Build PrEP Capacity among San Francisco Bay Area Clinicians.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  273. THOBAKGALE C, Naidoo K, McKinnon LR, Werner L, et al
    Interleukin 1-beta (IL-1beta) production by innate cells following TLR stimulation correlates with TB recurrence in ART-treated HIV infected patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  274. XIA Q, Teixeira-Pinto A, Forgione LA, Wiewel EW, et al
    Estimated HIV Incidence in the United States, 2003-2010.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  275. WAGNER AD, Wachira CM, Njuguna IN, Maleche-Obimbo E, et al
    Active referral of children of HIV-positive adults reveals high prevalence of undiagnosed HIV.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  276. HOSEK S, Rudy B, Landovitz R, Kapogiannis B, et al
    An HIV Pre-Exposure Prophylaxis (PrEP) Demonstration Project and Safety Study for Young MSM.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  277. WESTERCAMP M, Jaoko W, Mehta S, Abuor P, et al
    Changes in Male Circumcision Prevalence and Risk Compensation in the Kisumu, Kenya Population 2008-2013.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  278. YU F, Hao Y, Zhao H, Xiao J, et al
    Distinct Mitochondrial Disturbance in CD4+T and CD8+T Cells from HIV-infected Patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  279. DUFF P, Goldenberg S, Deering K, Montaner J, et al
    Barriers to Viral Suppression Among Female Sex Workers: Role of Structural and Intimate Partner Dynamics.
    J Acquir Immune Defic Syndr. 2016;73:83-90.
    PubMed     Text format     Abstract available


  280. KOOIJ KW, Schouten J, Wit FW, van der Valk M, et al
    Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency.
    J Acquir Immune Defic Syndr. 2016;73:55-62.
    PubMed     Text format     Abstract available


  281. BRENNAN AT, Long L, Useem J, Garrison L, et al
    Mortality in the First 3 Months on Antiretroviral Therapy Among HIV-Positive Adults in Low- and Middle-income Countries: A Meta-analysis.
    J Acquir Immune Defic Syndr. 2016;73:1-10.
    PubMed     Text format     Abstract available


  282. PADAYATCHI N, Naidu N, Yende-Zuma N, O'Donnell MR, et al
    Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis.
    J Acquir Immune Defic Syndr. 2016;73:e1-7.
    PubMed     Text format     Abstract available


  283. QUISPE CALLA NE, Vicetti Miguel RD, Trout W, Cherpes TL, et al
    HIV and Hormonal Contraception: Bench and Bedside.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  284. RONEN K, McGrath CJ, Langat AC, Kinuthia J, et al
    Gaps in Adolescent Engagement in Antenatal Care and Prevention of Mother-to-Child HIV Transmission Services in Kenya.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  285. GAMELL A, Glass TR, Luwanda LB, Mapesi H, et al
    An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


    August 2016
  286. PAGANELLA MP, Cohen RA, Harris DR, de Souza Kuchenbecker R, et al
    Association of Dyslipidemia and Glucose Abnormalities with Antiretroviral Treatment in a Cohort of HIV-infected Latin American Children.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  287. FLORIDIA M, Liotta G, Andreotti M, Galluzzo CM, et al
    Serum phosphate and creatinine levels in the first year of life in infants born to HIV-positive mothers receiving tenofovir-based combination regimens during pregnancy and prolonged breastfeeding in an option B+ programme in Malawi.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  288. GUO D, Zhou T, Arainga M, Palandri D, et al
    Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  289. HOLLOWAY I, Dougherty R, Gildner J, Beougher SC, et al
    PrEP Uptake, Adherence, and Discontinuation among California YMSM Using Geosocial Networking Applications.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  290. CANOUI E, Noel N, Lecuroux C, Boufassa F, et al
    Strong Ifitm1 Expression In Cd4 T Cells In Hiv Controllers Is Correlated With Immune Activation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  291. ELOPRE L, Kudroff K, Westfall AO, Overton ET, et al
    The Right People, Right Places, and Right Practices: Disparities in PrEP access among African American Men, Women and MSM in the Deep South.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  292. SHIN SS, Modongo C, Boyd R, Caiphus C, et al
    High Treatment Success Rates among HIV-infected Multidrug-resistant Tuberculosis Patients after Expansion of Antiretroviral Therapy in Botswana, 2006-2013.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  293. CALENDA G, Villegas G, Barnable P, Litterst C, et al
    MZC gel inhibits SHIV-RT and HSV-2 in macaque vaginal mucosa and SHIV-RT in rectal mucosa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  294. SAAG MS, Westfall AO, Cole SR, Mathews WC, et al
    Factors associated with the selection of initial antiretroviral therapy from 2009 to 2012.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  295. CHETWYND AJ, Samarawickrama A, Vera JH, Bremner SA, et al
    Nanoflow-nanospray mass spectrometry metabolomics reveals disruption of the urinary metabolite profiles of HIV-positive patients on combination antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  296. HANSCOM B, Janes HE, Guarino PD, Huang Y, et al
    Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  297. ESHLEMAN SH, Hudelson SE, Redd AD, Swanstrom R, et al
    Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  298. WYNDHAM-THOMAS C, Corbiere V, Selis E, Payen MC, et al
    Immune activation by Mycobacterium tuberculosis in HIV-infected and -uninfected subjects.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  299. THIRUMURTHY H, Masters SH, Rao S, Murray K, et al
    The Effects of Providing Fixed Compensation and Lottery-Based Rewards on Uptake of Medical Male Circumcision in Kenya: A Randomized Trial.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S299-305.
    PubMed     Text format     Abstract available


  300. KAUFMAN ZA, DeCelles J, Bhauti K, Hershow RB, et al
    A Sport-Based Intervention to Increase Uptake of Voluntary Medical Male Circumcision Among Adolescent Male Students: Results From the MCUTS 2 Cluster-Randomized Trial in Bulawayo, Zimbabwe.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S292-8.
    PubMed     Text format     Abstract available


  301. WILSON N, Frade S, Rech D, Friedman W, et al
    Advertising for Demand Creation for Voluntary Medical Male Circumcision.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S288-91.
    PubMed     Text format     Abstract available


  302. BAZANT E, Mahler H, Machaku M, Lemwayi R, et al
    A Randomized Evaluation of a Demand Creation Lottery for Voluntary Medical Male Circumcision Among Adults in Tanzania.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S280-7.
    PubMed     Text format     Abstract available


  303. SEMEERE AS, Castelnuovo B, Bbaale DS, Kiragga AN, et al
    Innovative Demand Creation for Voluntary Medical Male Circumcision Targeting a High Impact Male Population: A Pilot Study Engaging Pregnant Women at Antenatal Clinics in Kampala, Uganda.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S273-9.
    PubMed     Text format     Abstract available


  304. LEIBY K, Connor A, Tsague L, Sapele C, et al
    The Impact of SMS-Based Interventions on VMMC Uptake in Lusaka Province, Zambia: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S264-72.
    PubMed     Text format     Abstract available


  305. ZANOLINI A, Bolton C, Lyabola LL, Phiri G, et al
    Feasibility and Effectiveness of a Peer Referral Incentive Intervention to Promote Male Circumcision Uptake in Zambia.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S257-63.
    PubMed     Text format     Abstract available


  306. SINGH JA
    Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S252-5.
    PubMed     Text format     Abstract available


  307. HUGHES JP, Emel L, Hanscom B, Zangeneh S, et al
    Design Issues in Transgender Studies.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S248-51.
    PubMed     Text format     Abstract available


  308. SISKIND RL, Andrasik M, Karuna ST, Broder GB, et al
    Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S243-7.
    PubMed     Text format     Abstract available


  309. REISNER SL, Radix A, Deutsch MB
    Integrated and Gender-Affirming Transgender Clinical Care and Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S235-42.
    PubMed     Text format     Abstract available


  310. ANDERSON PL, Reirden D, Castillo-Mancilla J
    Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S230-4.
    PubMed     Text format     Abstract available


  311. GRANT RM, Sevelius JM, Guanira JV, Aguilar JV, et al
    Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S226-9.
    PubMed     Text format     Abstract available


  312. GAROFALO R, Kuhns LM, Reisner SL, Mimiaga MJ, et al
    Behavioral Interventions to Prevent HIV Transmission and Acquisition for Transgender Women: A Critical Review.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S220-5.
    PubMed     Text format     Abstract available


  313. POTEAT T, Scheim A, Xavier J, Reisner S, et al
    Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S210-9.
    PubMed     Text format     Abstract available


  314. MAYER KH, Grinsztejn B, El-Sadr WM
    Transgender People and HIV Prevention: What We Know and What We Need to Know, a Call to Action.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S207-9.
    PubMed     Text format     Abstract available


  315. KABAGAMBE EK, Ezeamama AE, Guwatudde D, Campos H, et al
    Plasma n6-fatty acid levels are associated with CD4 cell counts, hospitalization and mortality in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  316. CHAILLON A, Smith DM, Vanpouille C, Lisco A, et al
    HIV Trafficking between Blood and Semen during Early Untreated HIV Infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  317. AGUILAR-JIMENEZ W, Villegas-Ospina S, Gonzalez S, Zapata W, et al
    Active and precursor forms of Vitamin D reduce HIV-1 infection in vitro.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  318. SONG R, Hall HI, Green TA, Szwarcwald CL, et al
    Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of Undiagnosed Infections in the United States.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  319. NICHOLAS KJ, Flaherty DK, Smith RM, Sather DN, et al
    Chronic HIV-1 infection impairs superantigen-induced activation of peripheral CD4+CXCR5+PD-1+ cells, with relative preservation of recall antigen-specific responses.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  320. HARTLING HJ, Jespersen S, Gaardbo JC, Sambleben C, et al
    Reduced IL-7R T cell expression and increased plasma sCD127 in late presenting HIV-infected individuals.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  321. AARONS GA, Sommerfeld DH, Chi BH, Ezeanolue EE, et al
    Concept Mapping of PMTCT Implementation Challenges and Solutions Across 6 sub-Saharan African Countries in the NIH-PEPFAR PMTCT Implementation Science Alliance.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S202-6.
    PubMed     Text format     Abstract available


  322. CHIBWESHA CJ, Ford CE, Mollan KR, Stringer JS, et al
    Point-of-Care Virologic Testing to Improve Outcomes of HIV-Infected Children in Zambia: A Clinical Trial Protocol.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S197-201.
    PubMed     Text format     Abstract available


  323. MYER L, Phillips TK, Zerbe A, Ronan A, et al
    Optimizing Antiretroviral Therapy (ART) for Maternal and Child Health (MCH): Rationale and Design of the MCH-ART Study.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S189-96.
    PubMed     Text format     Abstract available


  324. NAPUA M, Pfeiffer JT, Chale F, Hoek R, et al
    Option B+ in Mozambique: Formative Research Findings for the Design of a Facility-Level Clustered Randomized Controlled Trial to Improve ART Retention in Antenatal Care.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S181-8.
    PubMed     Text format     Abstract available


  325. SHARMA M, Farquhar C, Ying R, Krakowiak D, et al
    Modeling the Cost-Effectiveness of Home-Based HIV Testing and Education (HOPE) for Pregnant Women and Their Male Partners in Nyanza Province, Kenya.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S174-80.
    PubMed     Text format     Abstract available


  326. KRAKOWIAK D, Kinuthia J, Osoti AO, Asila V, et al
    Home-Based HIV Testing Among Pregnant Couples Increases Partner Testing and Identification of Serodiscordant Partnerships.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S167-73.
    PubMed     Text format     Abstract available


  327. EZEANOLUE EE, Powell BJ, Patel D, Olutola A, et al
    Identifying and Prioritizing Implementation Barriers, Gaps, and Strategies Through the Nigeria Implementation Science Alliance: Getting to Zero in the Prevention of Mother-to-Child Transmission of HIV.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S161-6.
    PubMed     Text format     Abstract available


  328. PHARR JR, Obiefune MC, Ezeanolue CO, Osuji A, et al
    Linkage to Care, Early Infant Diagnosis, and Perinatal Transmission Among Infants Born to HIV-Infected Nigerian Mothers: Evidence From the Healthy Beginning Initiative.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S154-60.
    PubMed     Text format     Abstract available


  329. PRICE JT, Wheeler SB, Stranix-Chibanda L, Hosek SG, et al
    Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S145-53.
    PubMed     Text format     Abstract available


  330. FAYORSEY RN, Chege D, Wang C, Reidy W, et al
    Mother Infant Retention for Health (MIR4Health): Study Design, Adaptations, and Challenges With PMTCT Implementation Science Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S137-44.
    PubMed     Text format     Abstract available


  331. REIMERS P, Israel-Ballard K, Spies L, Tanser F, et al
    A Protocol for a Cluster Randomized Trial on the Effect of a "feeding buddy" Program on adherence to the Prevention of Mother-To-Child-Transmission Guidelines in a Rural Area of KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S130-6.
    PubMed     Text format     Abstract available


  332. YOTEBIENG M, Thirumurthy H, Moracco KE, Edmonds A, et al
    Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S124-9.
    PubMed     Text format     Abstract available


  333. BOEHMER A, Audet CM, Blevins M, Gebi UI, et al
    Patient and Provider Satisfaction With a Comprehensive Strategy to Improve Prevention of Mother-to-Child HIV Transmission Services in Rural Nigeria.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S117-23.
    PubMed     Text format     Abstract available


  334. GIMBEL S, Rustagi AS, Robinson J, Kouyate S, et al
    Evaluation of a Systems Analysis and Improvement Approach to Optimize Prevention of Mother-To-Child Transmission of HIV Using the Consolidated Framework for Implementation Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S108-16.
    PubMed     Text format     Abstract available


  335. PRASITSUEBSAI W, Teeraananchai S, Singtoroj T, Truong KH, et al
    Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in Asia.
    J Acquir Immune Defic Syndr. 2016;72:380-6.
    PubMed     Text format     Abstract available


  336. BUTLER K, Ritter JM, Ellis S, Morris MR, et al
    A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.
    J Acquir Immune Defic Syndr. 2016;72:363-71.
    PubMed     Text format     Abstract available


  337. GUST DA, Soud F, Hardnett F, Malotte CK, et al
    Evaluation of sexual risk behavior among study participants in the TDF2 PrEP study among heterosexual adults in Botswana.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  338. HAISSMAN JM, Haugaard AK, Knudsen A, Kristoffersen US, et al
    Marker of endothelial dysfunction asymmetric dimethylarginine is elevated in HIV infection but not associated with sub-clinical atherosclerosis.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  339. DAVIS NL, Miller WC, Hudgens MG, Chasela CS, et al
    Maternal and Breast Milk Viral Load: Impacts of Adherence on Peri-Partum HIV Infections Averted - the BAN Study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  340. MOORE CL, Grulich AE, Prestage G, Gidding HF, et al
    Hospitalisation for Anxiety and Mood Disorders in HIV-infected and -Uninfected Gay and Bisexual Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  341. KEATING SM, Kassanjee R, Lebedeva M, Facente SN, et al
    Performance of the Bio-Rad Geenius HIV1/2 supplemental assay in detecting 'recent' HIV infection and calculating population incidence.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  342. ALFONSO YN, Bishai D, Nantongo A, Kakembo R, et al
    Trends in the Marginal Cost of Male Circumcision in Rural Rakai Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


    July 2016
  343. CHANG W, Chamie G, Mwai D, Clark TD, et al
    Cost and efficiency of a hybrid mobile multi-disease testing approach with high HIV testing coverage in East Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  344. SSEMMONDO E, Mwangwa F, Kironde JL, Kwarisiima D, et al
    Population-based active TB case finding during large-scale mobile HIV testing campaigns in rural Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  345. GUHA A, Brier MR, Ortega M, Westerhaus E, et al
    Topographies of cortical and subcortical volume loss in HIV and aging in the cART era.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  346. LELUTIU-WEINBERGER C, Golub SA
    Enhancing PrEP Access for Black and Latino Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  347. AULD AF, Shiraishi RW, Couto A, Mbofana F, et al
    A Decade of Antiretroviral Therapy Scale-up in Mozambique: Evaluation of Outcome Trends and New Models of Service Delivery Among more than 300,000 Patients Enrolled during 2004[FIGURE DASH]2013.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  348. KARITA E, Nsanzimana S, Ndagije F, Wall KM, et al
    Evolution of Couples Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  349. FRIEDLAND BA, Hoesley CJ, Plagianos M, Hoskin E, et al
    A First-in-Human Trial of MIV-150 and Zinc Acetate Co-Formulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence and Pharmacodynamics.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  350. ONU CC, Dworkin SL, Ongeri LG, Oyaro P, et al
    Sexual violence against HIV-positive women in the Nyanza region of Kenya: Is condom negotiation an instigator?
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  351. PILCHER CD, Ospina-Norvell C, Dasgupta A, Jones D, et al
    The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a U.S. Public Health Setting.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  352. BENGTSON AM, Pence BW, Gaynes BN, Quinlivan EB, et al
    Improving depression among HIV-infected adults: transporting the effect of a depression treatment intervention to routine care.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  353. TRIPLETTE M, Attia E, Akgun K, Campo M, et al
    The differential impact of emphysema on respiratory symptoms and six-minute walk distance in HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  354. BEER L, Bradley H, Mattson CL, Johnson CH, et al
    Trends in racial and ethnic disparities in antiretroviral therapy prescription and viral suppression in the United States, 2009-2013: Trends in disparities in HIV care.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  355. PAN SW, Zhang Z, Li D, Carpiano RM, et al
    Religion and HIV sexual risk among men who have sex with men in China.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  356. SOBIESZCZYK ME, Werner L, Mlisana K, Naicker N, et al
    Metabolic syndrome after HIV acquisition in South African women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  357. SHRESTHA RK, Farnham PG, Whitham HK, Sansom SL, et al
    Challenges in Estimating Effectiveness of Condom Distribution Campaigns to Prevent HIV Transmission.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  358. YOUSEF KP, Meixenberger K, Smith MR, Somogyi S, et al
    Inferring HIV-1 transmission dynamics in Germany from recently transmitted viruses.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available



  359. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
    J Acquir Immune Defic Syndr. 2016;72:e82.
    PubMed     Text format    


  360. DIRIX V, Schepers K, Massinga-Loembe M, Worodria W, et al
    Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.
    J Acquir Immune Defic Syndr. 2016;72:344-52.
    PubMed     Text format     Abstract available


  361. GIRARD A, Vergnon-Miszczycha D, Depince-Berger AE, Roblin X, et al
    Brief Report: A High Rate of beta7+ Gut-Homing Lymphocytes in HIV-Infected Immunological Nonresponders is Associated With Poor CD4 T-Cell Recovery During Suppressive HAART.
    J Acquir Immune Defic Syndr. 2016;72:259-65.
    PubMed     Text format     Abstract available


    June 2016
  362. SUPERVIE V, Marty L, Lacombe JM, Dray-Spira R, et al
    Looking beyond the cascade of HIV care to end the AIDS epidemic: estimation of the time interval from HIV infection to viral suppression.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  363. CONROY AA, Gamarel KE, Neilands TB, Sauceda JA, et al
    Partner reports of HIV viral suppression predict sexual behavior in serodiscordant male couples.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  364. SAMUEL R, Julian MN, Paredes R, Parboosing R, et al
    HIV-1 Drug resistance by Ultra-deep sequencing following short course Zidovudine, single dose Nevirapine and single dose Tenofovir with Emtricitabine for pMTCT.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  365. CLIFFORD GM, de Vuyst H, Tenet V, Plummer M, et al
    Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  366. PECK RN, Wang RJ, Mtui G, Smart L, et al
    Linkage to primary care and survival after hospital discharge for HIV-infected adults in Tanzania: a prospective cohort study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  367. SLAVEN JE, Decker BS, Kashuba AD, Atta MG, et al
    Plasma and Intracellular Concentrations in HIV-infected Patients Requiring Hemodialysis Dosed with Tenofovir Disoproxil Fumarate and Emtricitabine: TDF and FTC in HD.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  368. KUNIHOLM MH, O'Brien TR, Prokunina-Olsson L, Augenbraun M, et al
    Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.
    J Acquir Immune Defic Syndr. 2016;72:162-70.
    PubMed     Text format     Abstract available


  369. SHET A, Nagaraja P, Dixit NM
    Viral decay dynamics and mathematical modeling of treatment response: evidence of lower in vivo fitness of HIV-1 subtype C.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  370. JUDGE CJ, Sandberg JK, Funderburg NT, Sherman KE, et al
    CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  371. FRAM F, Church F, Sundaram M, Sgaier SK, et al
    Employing Demand-Based Volumetric Forecasting to Identify Potential for and Roles of Devices in Scale-Up of Medical Male Circumcision in Zambia and Zimbabwe.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S83-9.
    PubMed     Text format     Abstract available


  372. MILOVANOVIC M, Taruberekera N, Martinson N, Lebina L, et al
    Perceptions of the PrePex Device Among Men Who Received or Refused PrePex Circumcision and People Accompanying Them.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S78-82.
    PubMed     Text format     Abstract available


  373. MUSIIGE AM, Ashengo TA, Stolarsky G, Dialwa RT, et al
    Participant Experiences and Views of Odor and PrePex Device Removal Pain in a VMMC Pilot Study in Botswana.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S73-7.
    PubMed     Text format     Abstract available


  374. KUFA T, Chetty-Makkan C, Maraisane M, Charalambous S, et al
    Delivering PrePex Medical Male Circumcision Services Through a Mobile Clinic: The Experience From a Pilot Project in North West Province, South Africa.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S69-72.
    PubMed     Text format     Abstract available


  375. MAVHU W, Hatzold K, Ncube G, Xaba S, et al
    Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S63-8.
    PubMed     Text format     Abstract available


  376. CUMMINGS B, Necochea E, Ferreira T, Soares B, et al
    Acceptability and Satisfaction Associated With the Introduction of the PrePex Circumcision Device in Maputo, Mozambique.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S56-62.
    PubMed     Text format     Abstract available


  377. SAMUELSON J, Hargreave T, Ridzon R, Farley T, et al
    Innovative Methods of Male Circumcision for HIV Prevention-Getting the Right Evidence.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S5-S12.
    PubMed     Text format     Abstract available


  378. FELDBLUM P, Martinson N, Bvulani B, Taruberekera N, et al
    Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S43-8.
    PubMed     Text format     Abstract available


  379. FELDBLUM PJ, Zulu R, Linyama D, Long S, et al
    Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S30-5.
    PubMed     Text format     Abstract available


  380. BARONE MA, Li PS, Zulu R, Awori QD, et al
    Men's Understanding of and Experiences During the Postcircumcision Abstinence Period: Results From a Field Study of ShangRing Circumcision During Routine Clinical Services in Kenya and Zambia.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S18-23.
    PubMed     Text format     Abstract available


  381. AWORI QD, Lee RK, Li PS, Zulu R, et al
    Surgical Outcomes of Newly Trained ShangRing Circumcision Providers.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S13-7.
    PubMed     Text format     Abstract available


  382. SO-ARMAH KA, Tate JP, Chang CH, Butt AA, et al
    Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
    J Acquir Immune Defic Syndr. 2016;72:206-213.
    PubMed     Text format     Abstract available


    May 2016
  383. BANGANI N, Nakiwala J, Martineau AR, Wilkinson RJ, et al
    HIV-1 infection impairs CD16 and CD35 mediated opsonophagocytosis of M.tuberculosis by human neutrophils.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  384. TABERNILLA A, Rego-Perez I, Grandal M, Pernas B, et al
    European Mitochondrial Haplogroups Impact on Liver Fibrosis Progression among HCV and HIV/HCV Coinfected Patients from Northwest Spain.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  385. CARRICO AW, Zepf R, Meanley S, Batchelder A, et al
    When the Party is Over: A Systematic Review of Behavioral Interventions for Substance-Using Men who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  386. MATHAD JS, Gupte N, Balagopal A, Asmuth D, et al
    Sex-related Differences in Inflammatory and Immune Activation Markers before and after combined Antiretroviral Therapy Initiation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  387. MONROE AK, Lau B, Mugavero MJ, Mathews WC, et al
    Heavy Alcohol Use is Associated with Worse Retention in HIV Care.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  388. HUERGA H, Van Cutsem G, Ben Farhat J, Reid M, et al
    Who needs to be targeted for HIV testing and treatment in KwaZulu-Natal? Results from a population-based survey.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  389. TUFA DM, Ahmad F, Chatterjee D, Ahrenstorf G, et al
    HIV-1 infection results in increased frequency of active and inflammatory slanDCs that produce high level of IL-1beta.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  390. BERGIN P, Langat R, Omosa-Manyonyi G, Farah B, et al
    Assessment of anti-HIV-1 antibodies in Oral and Nasal Compartments of Volunteers from Three different Populations.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  391. ROBERTS ST, Haberer J, Celum C, Mugo N, et al
    Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: A prospective cohort study.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  392. WENDELKEN LA, Jahanshad N, Rosen HJ, Busovaca E, et al
    ApoE epsilon4 is Associated with Cognition, Brain Integrity and Atrophy in HIV Over Age 60.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  393. E-B ROSSHEIM A, Cunningham TD, Hair PS, Shah T, et al
    Effects of Well-Controlled HIV Infection on Complement Activation and Function.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  394. GALLANT J, Brunetta J, Crofoot G, Benson P, et al
    Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) in HIV-1/Hepatitis B Coinfected Adults.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  395. YAHYAEI S, Biasin M, Saulle I, Gnudi F, et al
    Identification of a Specific miRNA Profile in HIV Exposed Seronegative Individuals.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  396. MCHUGH G, Rylance J, Mujuru H, Nathoo K, et al
    Chronic morbidity among older children and adolescents at diagnosis of HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  397. OKELLO S, Asiimwe SB, Kanyesigye M, Muyindike WR, et al
    D-dimer levels and traditional risk factors are associated with incident hypertension among HIV-infected individuals initiating antiretroviral therapy in Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  398. WEISS JJ, Konstantinidis I, Boueilh A, Fierer DS, et al
    Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults with HIV Infection and Hypertension or Chronic Kidney Disease.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  399. HERRIN M, Tate JP, Akgun KM, Butt AA, et al
    Weight Gain and Incident Diabetes among HIV Infected-Veterans Initiating Antiretroviral Therapy Compared to Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  400. MACLENNAN CA, Richter A, Hodson J, Faustini S, et al
    Immunization of HIV-infected adults in the UK with Haemophilus influenzae b/meningococcal C glycoconjugate and pneumococcal polysaccharide vaccines.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  401. BEYMER MR, Weiss RE, Halkitis PN, Kapadia F, et al
    Disparities within the Disparity - Determining HIV Risk Factors among Latino Gay and Bisexual Men Attending a Community-Based Clinic in Los Angeles, California.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  402. RAMGOPAL M, Osiyemi O, Zorrilla C, Crauwels HM, et al
    Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  403. ROY M, Muyindike W, Vijayan T, Kanyesigye M, et al
    Use of symptom screening and sputum microscopy testing for active tuberculosis case detection among HIV-infected patients in real-world clinical practice in Uganda.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  404. BRAUNSTEIN SL, Robertson MM, Myers J, Nash D, et al
    Using HIV Viral Load from Surveillance to Estimate the Timing of Antiretroviral Therapy Initiation.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format     Abstract available


  405. KNUDSEN A, Christensen TE, Thorsteinsson K, Ghotbi AA, et al
    Microbiota dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82Rubidium PET/CT.
    J Acquir Immune Defic Syndr. 2016.
    PubMed     Text format    


  406. TSUCHIYA K, Hayashida T, Hamada A, Oka S, et al
    Brief Report: High Peak Level of Plasma Raltegravir Concentration in Patients With ABCB1 and ABCG2 Genetic Variants.
    J Acquir Immune Defic Syndr. 2016;72:11-4.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: